The top executive at
Chairman and CEO
Bourla has received four shots of Comirnaty, the COVID-19 vaccine developed by the
More than 128 million people in
Scientists say the vaccine still offers solid protection against hospitalization and serious illness. But the evolving virus has made it tougher for vaccines to prevent all forms of illness from developing.
Paxlovid also has shown in research to be extremely effective at warding off serious illness if it is administered shortly after symptoms start.
Comirnaty and Paxlovid are the top-selling COVID-19 vaccine and treatment on the market. Combined, they brought in nearly
Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source